Memento Medicines
PrivateLast Round
Series A
Jun 18, 2026
Total Funding Raised
$93M
Company Overview
Memento Medicines is a biotechnology company developing biologic therapies for retinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Memento Medicines Comps
Public and private peers based on sector, stage, and business model.
Memento Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 18, 2026 |
Memento Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| Forbion | Series A |
| Sanofi Ventures | Series A |
| Samsara BioCapital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
$93M round led by RA Capital Management and Forbion.
Memento Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Memento Medicines's valuation, stock price, and market status.
